Yenilmez, E. D. Et Al. 2018. Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.. Combinatorial chemistry & high throughput screening , vol.21, no.5 , 374-380.

Yenilmez, E. D., Tamam, L., Karaytug, O., & TULİ, A., (2018). Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.. Combinatorial chemistry & high throughput screening , vol.21, no.5, 374-380.

Yenilmez, Ebru Et Al. "Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.," Combinatorial chemistry & high throughput screening , vol.21, no.5, 374-380, 2018

Yenilmez, Ebru D. Et Al. "Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.." Combinatorial chemistry & high throughput screening , vol.21, no.5, pp.374-380, 2018

Yenilmez, E. D. Et Al. (2018) . "Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.." Combinatorial chemistry & high throughput screening , vol.21, no.5, pp.374-380.

@article{article, author={Ebru Dundar Yenilmez Et Al. }, title={Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.}, journal={Combinatorial chemistry & high throughput screening}, year=2018, pages={374-380} }